Risk of recurrence at the time of withdrawal of short- or long-term methimazole therapy in patients with Graves’ hyperthyroidism: a randomized trial and a risk-scoring model
Fereidoun Azizi, Atieh Amouzegar, Davood Khalili, Hengameh Abdi, Maryam Tohidi, Mehdi Hedayati, Leila Cheraghi, Yadollah Mehrabi, Miralireza Takyar
Topics & Concepts
MedicineDiscontinuationInternal medicineProportional hazards modelRandomized controlled trialGraves' diseaseHazard ratioMethimazoleConfidence intervalThyroidThyroid Disorders and TreatmentsOphthalmology and Eye DisordersDiabetes and associated disorders